Signs of Macular Atrophy in nAMD Patients Treated with anti-VEGF
Investigators used OCT scans to identify anatomic alterations that precede macular atrophy.
Anti-VEGF Drugs
Fluctuations in Central Subfield Thickness Limit Effects of Anti-VEGF Therapy
Researchers found Central Subfield Thickness fluctuations were associated with lower visual acuity gains during a 52-week study.
Study: Intravitreal Injection Complications Decrease With Number of Prior Injections
The study also shows younger and female patients are more likely to report complications.
Laser Photocoagulation vs Intravitreal Injections for ROP Demonstrate Comparable Efficacy, Safety Outcomes
Laser photocoagulation and anti-VEGF intravitreal injections can be considered to treat retinopathy of prematurity.
Proposed Ranibizumab Biosimilar Meets Safety, Efficacy Endpoints for nAMD
A team of investigators sought to compare the safety and efficacy of proposed biosimilar FYB201 to reference ranibizumab in treatment-naive patients with subfoveal neovascular age-related macular degeneration.
Study Shows Impact of Birth Weight on Retinopathy of Prematurity
In a nationwide study across South Korea, researchers found associations with higher mortality and visual impairment.
Age Does Not Impact Anti-VEGF Treatment in Retinal Vein Occlusion
Researchers show no differences in therapeutic responses across age groups.
Choroidal Neovascularization Lesion Characteristics May Predict Reactivity
Study shows how lesion morphology is associated with rates of recurrence.
Intravitreal Injections Affirmed as Treatment Option for Some Central Serous Chorioretinopathy
A recent study shows new data supporting anti-VEGF therapy for patients with CSCR.
Intravitreal Injections Keep Patients Driving, Reading for Years
Research used driving and reading to measure visual usefulness for patients with Wet AMD.
-
Loading...
-
Loading...
Next post in Systemic Ophthalmology
